Which Antidepressants Reduce Libido Most in Men?
SSRIs and some SNRIs reduce libido in some men, but comparative evidence does not identify one antidepressant as the worst for every man; many studies measure several sexual symptoms together.
Libido means sexual desire. Antidepressant-related sexual dysfunction also includes erection, ejaculation and orgasm problems. A combined sexual-function score does not measure the percentage of men who lose sexual desire.
Which antidepressants have higher sexual side-effect rates?
SSRIs and venlafaxine XR had higher rates of combined sexual dysfunction than bupropion in a large observational study; those results describe an association rather than a definitive ranking of male libido loss.
Clayton and colleagues studied 6,297 adults taking one antidepressant in 1,101 US primary-care clinics: 4,534 women and 1,763 men. The study used the Changes in Sexual Functioning Questionnaire. It was cross-sectional, not a randomized comparison. [1]
| Antidepressant | Reported prevalence | Interpretation for male libido |
|---|---|---|
| Bupropion immediate release | 22% | Combined outcome in men and women; not male low-desire prevalence. |
| Bupropion sustained release | 25% | A lower observed rate does not mean zero sexual side effects. |
| SSRIs, mirtazapine and venlafaxine XR | 36–43% across these treatment groups | The range does not establish a universal worst drug for desire. |
These figures come from the same study and questionnaire. They describe existing sexual dysfunction during treatment, rather than proving that medication caused every symptom. They also show why mirtazapine should not be described as uniformly free of sexual problems. [1]
Do SNRIs reduce libido as well as SSRIs?
SNRIs cause sexual side effects, including reduced libido; the risk depends on the medicine and the person rather than a simple class-wide ranking.
Venlafaxine extended-release prescribing information reports decreased libido in 5.1% of treated participants and 1.6% of placebo participants in pooled trials lasting up to 12 weeks. The groups contained 3,558 and 2,197 participants, respectively. These libido figures are not restricted to men. [2]
The label figures measure reported adverse events. The observational study above used a sexual-function questionnaire. Different methods, populations and follow-up periods explain why these percentages should not be combined into one league table. The label explicitly cautions against comparing adverse-event rates across separate drug trials. [2]
Which antidepressants have evidence for fewer sexual problems?
Bupropion has evidence for fewer combined sexual problems in some comparisons, and vortioxetine improved sexual-function scores more than escitalopram in one switching trial; neither finding guarantees restored libido.
A 2015 randomized trial enrolled 447 adults whose depression responded to citalopram, paroxetine or sertraline but who developed sexual dysfunction. Participants switched to vortioxetine (225 people) or escitalopram (222 people) for eight weeks. [3]
Average improvement on the CSFQ-14 sexual-function questionnaire was 8.8 points with vortioxetine and 6.6 points with escitalopram (p=0.013). These are score changes, not percentages of men whose libido returned. Depression outcomes remained similar between groups. The study examined selected adults of both sexes with existing treatment-related symptoms. [3]
Antidepressant selection balances sexual function, psychiatric response and other adverse effects. A drug that produces fewer sexual symptoms in a study still requires an individual safety assessment. Read the focused guide to bupropion and male libido for its evidence and prescribing constraints.
How do you distinguish low libido from other antidepressant effects?
Antidepressant-related low libido means reduced sexual interest; erection, ejaculation and orgasm difficulties describe different symptoms that require separate assessment.
- Describe desire when sexual thoughts or interest decline.
- Describe erection problems when interest remains but erections are unreliable.
- Describe orgasm problems when arousal occurs but climax becomes delayed or absent.
- Record overlapping symptoms when more than one part of sexual function changes.
For example, a man who wants sex but cannot reach orgasm has a different complaint from a man who loses interest in sex. Both symptoms merit discussion with the prescriber. The NHS lists reduced desire, orgasm difficulty and erection difficulty separately among antidepressant side effects. [4]
How should men discuss reduced libido with a prescriber?
Men should report reduced libido with its timing, medication history and effect on daily life so the prescriber can assess treatment-related symptoms and other explanations.
- Record sexual desire before treatment, after starting the antidepressant and after dose changes.
- Separate desire changes from erection, ejaculation and orgasm problems.
- List all medicines, supplements and alcohol use.
- Explain whether mood improved while libido declined.
- Agree on follow-up after any treatment adjustment.
A symptom that begins after a dose change provides useful timing evidence. Timing alone does not prove the antidepressant caused it. The venlafaxine label advises clinicians to ask about sexual function before treatment and during follow-up. [2] See the separate guide to SSRIs and male libido for SSRI-specific assessment.
Should men skip antidepressant doses to improve libido?
Men should not skip antidepressant doses or stop treatment abruptly to improve libido; medication changes require a plan agreed with the prescriber.
NICE recommends reducing antidepressant doses in stages when stopping treatment. Withdrawal symptoms and the person’s response determine the pace. A self-directed weekend drug holiday is not equivalent to a supervised medication change. [5]
Persistent sexual symptoms deserve reassessment rather than a promised recovery deadline. The NHS states that sexual problems continue after stopping antidepressants in some people. Seek prompt help for new suicidal thoughts or an urge to self-harm; use emergency services when immediate safety is at risk. [4]
Which sources support this antidepressant and libido comparison?
This antidepressant comparison uses primary research, prescribing information and official guidance; each numerical result retains its population, outcome and study design.
- Clayton et al. (2002). Prevalence of Sexual Dysfunction Among Newer Antidepressants.
- Pfizer. Venlafaxine extended-release prescribing information, sections 5.13 and 6.1.
- Jacobsen et al. (2015). Vortioxetine versus escitalopram after SSRI-related sexual dysfunction.
- NHS. Antidepressants: sexual side effects, safety and stopping treatment.
- NICE NG222. Depression in adults: treatment and management.
